Crinetics Pharmaceuticals In shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crinetics Pharmaceuticals In by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $253M | 4.9M | 51.10 |
| 2024-06-30 | $197M | 4.4M | 44.79 |
| 2024-03-31 | $179M | 3.8M | 46.81 |
| 2023-12-31 | $107M | 3.0M | 35.58 |
| 2023-09-30 | $77M | 2.6M | 29.74 |
| 2023-06-30 | $26M | 1.4M | 18.02 |
| 2023-03-31 | $671k | 42k | 16.06 |
| 2022-12-31 | $951k | 52k | 18.31 |
| 2022-03-31 | $825k | 38k | 21.95 |
| 2021-12-31 | $2.2M | 77k | 28.42 |
| 2021-09-30 | $1.4M | 66k | 21.05 |
| 2021-06-30 | $1.2M | 66k | 18.85 |
| 2021-03-31 | $747k | 49k | 15.29 |
| 2020-12-31 | $1.1M | 81k | 14.12 |
| 2020-09-30 | $1.3M | 86k | 15.67 |
| 2020-06-30 | $1.5M | 86k | 17.52 |
| 2020-03-31 | $418k | 28k | 14.71 |
| 2019-12-31 | $906k | 36k | 25.09 |
| 2019-09-30 | $786k | 52k | 15.03 |
| 2019-06-30 | $12M | 488k | 25.00 |
| 2019-03-31 | $11M | 486k | 22.76 |
| 2018-12-31 | $13M | 434k | 29.99 |
| 2018-09-30 | $12M | 434k | 28.65 |